Clinical trial

Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation

NCT01513655

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention LTNIV Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE4

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Acute Exacerbation of Chronic Obstructive Airways Diseaseunresolved

Chronic Hypercapnic Respiratory Failureunresolved

Interventions

LTNIVDEVICE

Sponsors & collaborators

University Hospital, Gentofte, Copenhagenlead sponsor

Philips Respironicscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01513655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.